did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780824703141

Clinical Drug Trials and Tribulations, Revised and Expanded, Second Edition

by
  • ISBN13:

    9780824703141

  • ISBN10:

    0824703146

  • Edition: 2nd
  • Format: Hardcover
  • Copyright: 2002-03-26
  • Publisher: CRC Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $210.00 Save up to $77.70
  • Rent Book $132.30
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-5 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

Aimed at those already involved in drug development or those considering entering the field, Clinical Drug Trials and Tribulations, Second Edition comprehensibly addresses the new, day-to-day challenges of drug development with valuable assessments of the areas affecting the conduction of nonclinical and clinical studies. Addressing which decisions should be made during drug development, this updated and expanded text/reference carefully guides readers through the various trials and tribulations that emerge phase-by-phase and are pertinent to all levels of pharmaceutical or clinical drug management. Bringing together the latest information on drug development, the Second Edition contains: new material on⬦ international regulation and deregulation venture capitalist investment the IND process informed consent changes in manufacturing and updated and extended coverage of⬦ pediatric drug trial design the advantages and disadvantages of orphan drug designations the maximization of package inserts for marketing post approval safety surveillance withdrawals from the drug market Clinical Drug Trials and Tribulations, Second Edition will prove an invaluable reference for pharmacologists, pharmacists, clinical chemists, clinical coordinators, clinical monitors, government drug regulatory personnel, and bioethicists as well as a useful text for medical or pharmacy school courses on pharmaceutical development and research.

Table of Contents

Preface v
Contributors xi
Current Challenges and Future Directions of Drug Development
1(20)
Allen Cato
Lynda Sutton
Allen Cato III
Preclinical Drug Discovery and Development
21(26)
David S. Duch
Robert M. Ferris
The IND Process for New Drug Products
47(18)
David M. Cocchetto
Performance and Interpretation of Laboratory Tests
65(14)
W. Leigh Thompson
Rocco L. Brunelle
Michael G. Wilson
Issues in Endpoint Selection
79(14)
Karen D. Weiss
Jay Philip Siegel
Dix, Cent, Mille: Proof of Principle with $10 Million, 100 Patients, and 1000 Days
93(20)
W. Leigh Thompson
Clinical Drug Trials in Pediatrics: Dilemmas of Clinical Drug Trials in Pediatric Populations
113(14)
Allen Cato
Myron B. Peterson
Electronic Capture of Clinical Trial Information
127(8)
Daniel C. Cato
David B. Thomas
Providing Patient Access to Promising Investigational Drugs
135(14)
Peggy J. Berry
Allen Cato
Issues in the Review of Clinical Drug Trials by IRBs
149(28)
Dale H. Cowan
Personal Care and Randomized Clinical Trials: Understanding the Ethical Conflicts
177(22)
Paul J. Reitemeier
Informed Consent in Clinical Trials: Emerging Issues
199(22)
Cheryl K. Fiedler
H. Russell Searight
Orphan Drug Development: David and Goliath
221(12)
Allen Cato
Susan L. Watts
Lynda Sutton
Marlene E. Haffner
Single-Event Adverse Drug Reactions: Tribulations in Ascribing Causality
233(20)
Nelson S. Irey
How to Deal with a Sudden, Unexpected Death in Clinical Studies
253(10)
Allen Cato
Lynda Sutton
Clinical Trial Material-The Fuel for Clinical Research
263(18)
David F. Bernstein
The Role of Pharmacokinetics in Drug Development
281(38)
Allen Cato III
Richard Granneman
Building an NDA/BLA
319(24)
Diana E. Fordyce
Angela Cahill
International Planning of Drug Clinical Trials
343(18)
David L. Horwitz
Uncertainty in Drug Development: Approval Success Rates for New Drugs
361(18)
Joseph A. DiMasi
Contract Clinical Research: Value to In-House Drug Development
379(12)
F. Richard Nichol
Package Inserts as Viewed by the Busy Private Practitioner
391(12)
Jean M. Findlay
New Directions in Pharmaceutical Promotion: Regulatory Concerns and Contrivances
403(10)
Louis A. Morris
Peter H. Rheinstein
The Campus Researcher and Industry: Issues of Intellectual Property and Technology Transfer
413(10)
Todd S. Keiller
Anatomy of Drug Withdrawals in the United States
423(16)
Marion J. Finkel
Appendices: Routine Clinical Analyte Test Results 439(12)
Index 451

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program